Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 10.25 USD -5.62% Market Closed
Market Cap: 468.2m USD

Intrinsic Value

The intrinsic value of one CAPR stock under the Base Case scenario is 39.98 USD. Compared to the current market price of 10.25 USD, Capricor Therapeutics Inc is Undervalued by 74%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CAPR Intrinsic Value
39.98 USD
Undervaluation 74%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Capricor Therapeutics Inc

Valuation History Unavailable

Historical valuation for CAPR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Capricor Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Capricor Therapeutics Inc

Current Assets 146.3m
Cash & Short-Term Investments 144.8m
Receivables 59.8k
Other Current Assets 1.4m
Non-Current Assets 7.5m
PP&E 7.3m
Other Non-Current Assets 253.4k
Efficiency

Free Cash Flow Analysis
Capricor Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Capricor Therapeutics Inc

Revenue
17.4m USD
Operating Expenses
-74.6m USD
Operating Income
-57.3m USD
Other Expenses
2.2m USD
Net Income
-55.1m USD
Fundamental Scores

CAPR Profitability Score
Profitability Due Diligence

Capricor Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROIC is Increasing
38/100
Profitability
Score

Capricor Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

CAPR Solvency Score
Solvency Due Diligence

Capricor Therapeutics Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Capricor Therapeutics Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CAPR Price Targets Summary
Capricor Therapeutics Inc

Wall Street analysts forecast CAPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAPR is 44.59 USD with a low forecast of 25.25 USD and a high forecast of 80.85 USD.

Lowest
Price Target
25.25 USD
146% Upside
Average
Price Target
44.59 USD
335% Upside
Highest
Price Target
80.85 USD
689% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Capricor Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CAPR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CAPR Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CAPR stock?

The intrinsic value of one CAPR stock under the Base Case scenario is 39.98 USD.

Is CAPR stock undervalued or overvalued?

Compared to the current market price of 10.25 USD, Capricor Therapeutics Inc is Undervalued by 74%.

Back to Top